51885-9494 NDC - ALPHA LIPOIC ACID, ARNICA MONTANAROOT,SUS SCROFA CARTILAGE,COENZYME A, SOLANUM DULCAMARA TOP, SUS SCROFA EMBRYO,SUS SCROFA UMBILICAL CORD,NADIDE,SODIUM DIETHYL OXALACETATE, SUS SCROFA PLACENTA,TOXICODENDRON PUBESCENS LEAF,SANGUINARIA CANADENSIS ROOT,SILICON DIOXIDE,SULFUR,COMFREY ROOT

Drug Information

Product NDC: 51885-9494
Proprietary Name:
Non Proprietary Name: ALPHA LIPOIC ACID, ARNICA MONTANAROOT,SUS SCROFA CARTILAGE,COENZYME A, SOLANUM DULCAMARA TOP, SUS SCROFA EMBRYO,SUS SCROFA UMBILICAL CORD,NADIDE,SODIUM DIETHYL OXALACETATE, SUS SCROFA PLACENTA,TOXICODENDRON PUBESCENS LEAF,SANGUINARIA CANADENSIS ROOT,SILICON DIOXIDE,SULFUR,COMFREY ROOT
Active Ingredient(s): 6 [hp_X]/1 ALPHA LIPOIC ACID; 1 [hp_X]/1 ARNICA MONTANA ROOT; 6 [hp_X]/1 COENZYME A; 8 [hp_X]/1 COMFREY ROOT; 6 [hp_X]/1 NADIDE; 3 [hp_X]/1 SANGUINARIA CANADENSIS ROOT; 6 [hp_X]/1 SILICON DIOXIDE; 6 [hp_X]/1 SODIUM DIETHYL OXALACETATE; 2 [hp_X]/1 SOLANUM DULCAMARA TOP; 6 [hp_X]/1 SULFUR; 4 [hp_X]/1 SUS SCROFA CARTILAGE; 4 [hp_X]/1 SUS SCROFA EMBRYO; 4 [hp_X]/1 SUS SCROFA PLACENTA; 4 [hp_X]/1 SUS SCROFA UMBILICAL CORD; 2 [hp_X]/1 TOXICODENDRON PUBESCENS LEAF
Administration Route(s):
Dosage Form(s): TABLET

Labeler Information

Field Name	Field Value
Labeler Name:	Biologische Heilmittel Heel
Product Type:	DRUG FOR FURTHER PROCESSING
FDA Application Number:
Marketing Category:	DRUG FOR FURTHER PROCESSING
Start Marketing Date:	9/10/2021

Package Information

No.	Package Code	Package Description	Billing Unit
1	51885-9494-2	1 BAG in 1 BOX (51885-9494-2) / 1 TABLET in 1 BAG

NDC Record

Field Name	Field Value	Definition
PRODUCT NDC	51885-9494	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAME	DRUG FOR FURTHER PROCESSING	Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
NON PROPRIETARY NAME	ALPHA LIPOIC ACID, ARNICA MONTANAROOT,SUS SCROFA CARTILAGE,COENZYME A, SOLANUM DULCAMARA TOP, SUS SCROFA EMBRYO,SUS SCROFA UMBILICAL CORD,NADIDE,SODIUM DIETHYL OXALACETATE, SUS SCROFA PLACENTA,TOXICODENDRON PUBESCENS LEAF,SANGUINARIA CANADENSIS ROOT,SILICON DIOXIDE,SULFUR,COMFREY ROOT	The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAME	TABLET	The translation of the dosage form Code submitted by the firm.
START MARKETING DATE	9/10/2021	This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAME	DRUG FOR FURTHER PROCESSING	Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAME	Biologische Heilmittel Heel	Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAME	ALPHA LIPOIC ACID; ARNICA MONTANA ROOT; COENZYME A; COMFREY ROOT; NADIDE; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE; SODIUM DIETHYL OXALACETATE; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA CARTILAGE; SUS SCROFA EMBRYO; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; TOXICODENDRON PUBESCENS LEAF	An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH	6; 1; 6; 8; 6; 3; 6; 6; 2; 6; 4; 4; 4; 4; 2
ACTIVE INGRED UNIT	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1

Drug Information

Labeler Information

Package Information

NDC Record

Download Record